<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_apelin" title="Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis" shortTitle="apelin" author="Pedro Melgar-Lesmes, Meritxell Perramon, Wladimiro Jiménez" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2073-4409/8/11/1311/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
7.	LS	7.
Involvement	NN	involvement
of	IN	of
the	DT	the
Apelin	NNP	Apelin
System	NNP	system
in	IN	in
the	DT	the
Pathogenesis	NNP	Pathogenesis
of	IN	of
Liver	NNP	Liver
Fibrosis	NNP	Fibrosis
</s>
</head>
<p>
<s type="decl">
The	DT	the
apelin	NN	apelin
system	NN	system
has	VBZ	have
certain	JJ	certain
therapeutic	JJ	therapeutic
abilities	NNS	ability
,	,	,
but	CC	but
it	PRP	it
may	MD	may
also	RB	also
play	VB	play
a	DT	a
role	NN	role
in	IN	in
disease	NN	disease
depending	VBG	depend
on	IN	on
the	DT	the
cellular	JJ	cellular
and	CC	and
molecular	JJ	molecular
milieu	NN	milieu
.	.	.
</s>
<s type="decl">
A	DT	a
clear	JJ	clear
example	NN	example
of	IN	of
this	DT	this
is	VBZ	be
the	DT	the
role	NN	role
of	IN	of
apelin	NN	apelin
in	IN	in
tissue	NN	tissue
fibrosis	NN	fibrosis
.	.	.
</s>
<s type="decl">
Apelin	NNP	Apelin
displays	VBZ	display
anti-fibrotic	JJ	anti-fibrotic
actions	NNS	action
counteracting	VBG	counteract
AII	NNP	AII
in	IN	in
models	NNS	model
of	IN	of
cardiac	JJ	cardiac
fibrosis	NN	fibrosis
and	CC	and
renal	JJ	renal
fibrosis	NN	fibrosis
.	.	.
</s>
<s type="decl">
In	IN	in
contrast	NN	contrast
,	,	,
the	DT	the
scenario	NN	scenario
and	CC	and
role	NN	role
of	IN	of
the	DT	the
apelin	NN	apelin
system	NN	system
are	VBP	be
completely	RB	completely
different	JJ	different
in	IN	in
liver	NN	liver
disease	NN	disease
.	.	.
</s>
<s type="decl">
Apelin	NNP	Apelin
is	VBZ	be
a	DT	a
hepatic	JJ	hepatic
pro-fibrotic	JJ	pro-fibrotic
agent	NN	agent
,	,	,
in	IN	in
part	NN	part
by	IN	by
mediating	VBG	mediate
some	DT	some
of	IN	of
the	DT	the
fibrogenic	JJ	fibrogenic
effects	NNS	effect
triggered	VBN	trigger
by	IN	by
AII	NNP	AII
and	CC	and
ET-1	NNP	ET-1
in	IN	in
the	DT	the
activation	NN	activation
of	IN	of
HSC	NNP	HSC
occurring	VBG	occur
in	IN	in
liver	NN	liver
fibrosis	NN	fibrosis
.	.	.
</s>
<s type="decl">
These	DT	this
outcomes	NNS	outcome
highlight	VBP	highlight
the	DT	the
intriguing	JJ	intrigue
difference	NN	difference
between	IN	between
myofibroblastic-cell	JJ	myofibroblastic-cell
types	NNS	type
in	IN	in
liver	NN	liver
compared	VBN	compare
to	IN	to
myofibroblasts	NNS	myofibroblast
in	IN	in
heart	NN	heart
,	,	,
kidney	NN	kidney
,	,	,
or	CC	or
skin	NN	skin
in	IN	in
which	WDT	which
apelin	NN	apelin
acts	VBZ	act
by	IN	by
decreasing	VBG	decrease
myofibroblast	NN	myofibroblast
accumulation	NN	accumulation
and	CC	and
activity	NN	activity
.	.	.
</s>
<s type="decl">
In	IN	in
vitro	NN	vitro
,	,	,
apelin	NN	apelin
has	VBZ	have
also	RB	also
demonstrated	VBN	demonstrate
a	DT	a
significant	JJ	significant
potential	NN	potential
to	TO	to
promote	VB	promote
liver	NN	liver
fibrosis	NN	fibrosis
.	.	.
</s>
<s type="decl">
It	PRP	it
acts	VBZ	act
directly	RB	directly
on	IN	on
LX-2	NNP	LX-2
cells	NNS	cell
(	-LRB-	(
a	DT	a
cell	NN	cell
line	NN	line
used	VBN	use
as	IN	as
a	DT	a
reliable	JJ	reliable
in	IN	in
vitro	NN	vitro
model	NN	model
of	IN	of
HSC	NNP	HSC
)	-RRB-	)
through	IN	through
Erk	NNP	Erk
signalling	NN	signalling
,	,	,
stimulating	VBG	stimulate
cell	NN	cell
survival	NN	survival
and	CC	and
the	DT	the
synthesis	NN	synthesis
of	IN	of
PDGF-β	NN	PDGF-β
receptor	NN	receptor
and	CC	and
collagen-I	NN	collagen-I
in	IN	in
these	DT	this
cells	NNS	cell
.	.	.
</s>
<s type="decl">
In	IN	in
turn	NN	turn
,	,	,
PDGF-β	NNP	PDGF-β
and	CC	and
LPS	NN	LPS
can	MD	can
stimulate	VB	stimulate
the	DT	the
expression	NN	expression
of	IN	of
APJ	NNP	APJ
,	,	,
expanding	VBG	expand
and	CC	and
perpetuating	VBG	perpetuate
HSC	NNP	HSC
activation	NN	activation
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
apelin	NN	apelin
may	MD	may
,	,	,
in	IN	in
theory	NN	theory
,	,	,
induce	VB	induce
HSC	NNP	HSC
to	IN	to
a	DT	a
pro-fibrogenic	JJ	pro-fibrogenic
profile	NN	profile
and	CC	and
prolong	VB	prolo
its	PRP$	its
stimulation	NN	stimulation
autocrinally	RB	autocrinally
during	IN	during
all	DT	all
stages	NNS	stage
of	IN	of
liver	NN	liver
fibrosis	NN	fibrosis
in	IN	in
chronic	JJ	chronic
liver	NN	liver
disease	NN	disease
(	:	(
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
6	CD	6
</s>
</figure>
<s type="frag">
)	-RRB-	)
.	.	.
</s>
<s type="decl">
In	IN	in
fact	NN	fact
,	,	,
some	DT	some
data	NNS	datum
have	VBP	have
revealed	VBN	reveal
that	IN	that
the	DT	the
inhibition	NN	inhibition
of	IN	of
APJ	NNP	APJ
using	VBG	use
F13A	NNP	F13A
(	-LRB-	(
an	DT	a
APJ	NNP	APJ
antagonist	NN	antagonist
)	-RRB-	)
prevents	VBZ	prevent
fibrosis	NN	fibrosis
progression	NN	progression
in	IN	in
rats	NNS	rat
under	IN	under
a	DT	a
non-discontinued	JJ	non-discontinued
fibrosis	NN	fibrosis
induction	NN	induction
program	NN	program
using	VBG	use
CCl4	NNP	CCl4
.	.	.
</s>
</p>
<p>
<s type="decl">
Several	JJ	several
investigations	NNS	investigation
have	VBP	have
uncovered	VBN	uncover
the	DT	the
close	JJ	close
and	CC	and
integrated	VBN	integrate
relationship	NN	relationship
between	IN	between
pathological	JJ	pathological
angiogenesis	NN	angiogenesis
and	CC	and
fibrosis	NN	fibrosis
.	.	.
</s>
<s type="decl">
As	IN	as
mentioned	VBN	mention
above	RB	above
,	,	,
apelin	NN	apelin
is	VBZ	be
a	DT	a
powerful	JJ	powerful
angiogenic	JJ	angiogenic
agent	NN	agent
through	IN	through
the	DT	the
activation	NN	activation
of	IN	of
endothelial	JJ	endothelial
APJ	NNP	APJ
and	CC	and
different	JJ	different
downstream	JJ	downstream
signalling	NN	signalling
pathways	NNS	pathway
.	.	.
</s>
<s type="decl">
Two	CD	2
reports	NNS	report
have	VBP	have
associated	VBN	associate
the	DT	the
inhibition	NN	inhibition
of	IN	of
APJ	NNP	APJ
with	IN	with
a	DT	a
reduction	NN	reduction
in	IN	in
angiogenesis	NN	angiogenesis
and	CC	and
with	IN	with
a	DT	a
concomitant	JJ	concomitant
drop	NN	drop
in	IN	in
fibrosis	NN	fibrosis
in	IN	in
CH	NN	CH
and	CC	and
fibrotic	JJ	fibrotic
rats	NNS	rat
.	.	.
</s>
<s type="decl">
Although	IN	although
a	DT	a
direct	JJ	direct
relationship	NN	relationship
was	VBD	be
not	RB	not
established	VBN	establish
between	IN	between
the	DT	the
two	CD	2
phenomena	NNS	phenomenon
,	,	,
there	EX	there
are	VBP	be
evidence	NN	evidence
pointing	VBG	point
out	RP	out
that	IN	that
APJ	NNP	APJ
activation	NN	activation
by	IN	by
apelin	NN	apelin
stimulates	VBZ	stimulate
the	DT	the
expression	NN	expression
of	IN	of
a	DT	a
well-known	JJ	well-known
pro-angiogenic	JJ	pro-angiogenic
factor	NN	factor
,	,	,
angiopoietin-1	NN	angiopoietin-1
(	-LRB-	(
from	IN	from
the	DT	the
angiopoietin	NN	angiopoietin
family	NN	family
involved	VBN	involve
in	IN	in
pathological	JJ	pathological
angiogenesis	NN	angiogenesis
in	IN	in
chronic	JJ	chronic
liver	NN	liver
disease	NN	disease
)	-RRB-	)
in	IN	in
LX-2	NNP	LX-2
cells	NNS	cell
.	.	.
</s>
<s type="decl">
This	DT	this
suggests	VBZ	suggest
that	IN	that
fibrogenic	JJ	fibrogenic
cells	NNS	cell
such	JJ	such
as	IN	as
HSC	NNP	HSC
may	MD	may
participate	VB	participate
in	IN	in
hepatic	JJ	hepatic
angiogenesis	NN	angiogenesis
by	IN	by
secreting	VBG	secret
angiogenic	JJ	angiogenic
factors	NNS	factor
such	JJ	such
as	IN	as
angiopoietin	NN	angiopoietin
1	CD	1
.	.	.
</s>
<s type="decl">
Indeed	RB	indeed
,	,	,
the	DT	the
inhibition	NN	inhibition
of	IN	of
HSC-secreted	NNP	HSC-secreted
angiopietin-1	NN	angiopietin-1
has	VBZ	have
shown	VBN	show
to	TO	to
drastically	RB	drastically
reduce	VB	reduce
pathological	JJ	pathological
angiogenesis	NN	angiogenesis
and	CC	and
liver	NN	liver
fibrosis	NN	fibrosis
induced	VBN	induce
in	IN	in
mice	NNS	mouse
by	IN	by
either	CC	either
CCl4	NNP	CCl4
or	CC	or
BDL	NNP	BDL
.	.	.
</s>
</p>
<p>
<s type="decl">
Aside	RB	aside
from	IN	from
HSC	NNP	HSC
,	,	,
hepatocytes	NNS	hepatocyte
have	VBP	have
also	RB	also
been	VBN	be
related	VBN	relate
to	TO	to
contribute	VB	contribute
to	IN	to
both	DT	both
phenomena	NNS	phenomenon
,	,	,
pathological	JJ	pathological
angiogenesis	NN	angiogenesis
and	CC	and
liver	NN	liver
fibrosis	NN	fibrosis
,	,	,
by	IN	by
releasing	VBG	release
pro-angiogenic	JJ	pro-angiogenic
and	CC	and
pro-fibrogenic	JJ	pro-fibrogenic
factors	NNS	factor
.	.	.
</s>
<s type="decl">
There	EX	there
is	VBZ	be
a	DT	a
growing	VBG	grow
belief	NN	belief
that	IN	that
local	JJ	local
hypoxia	NN	hypoxia
is	VBZ	be
the	DT	the
link	NN	link
interconnecting	VBG	interconnect
both	CC	both
pathological	JJ	pathological
angiogenesis	NN	angiogenesis
and	CC	and
liver	NN	liver
fibrogenesis	NN	fibrogenesis
,	,	,
orchestrating	VBG	orchestrate
the	DT	the
harmonic	JJ	harmonic
and	CC	and
coordinated	VBN	coordinate
activation	NN	activation
of	IN	of
HSC	NNP	HSC
,	,	,
hepatocytes	NNS	hepatocyte
and	CC	and
other	JJ	other
hepatic	JJ	hepatic
cells	NNS	cell
.	.	.
</s>
<s type="decl">
Detection	NN	detection
of	IN	of
hypoxic	JJ	hypoxic
areas	NNS	area
is	VBZ	be
a	DT	a
common	JJ	common
trait	NN	trait
at	IN	at
any	DT	any
stage	NN	stage
of	IN	of
chronic	JJ	chronic
liver	NN	liver
disease	NN	disease
,	,	,
expanding	VBG	expand
progressively	RB	progressively
from	IN	from
early	JJ	early
injury	NN	injury
to	IN	to
the	DT	the
development	NN	development
of	IN	of
cirrhosis	NN	cirrhosis
.	.	.
</s>
<s type="decl">
,	,	,
Through	IN	through
the	DT	the
action	NN	action
of	IN	of
hypoxia-inducible	JJ	hypoxia-inducible
factors	NNS	factor
(	-LRB-	(
HIF	NNP	HIF
)	-RRB-	)
,	,	,
hepatic	JJ	hepatic
hypoxia	NN	hypoxia
up-regulates	VBZ	up-regulate
the	DT	the
expression	NN	expression
of	IN	of
a	DT	a
wide	JJ	wide
array	NN	array
of	IN	of
growth	NN	growth
factors	NNS	factor
and	CC	and
mediators	NNS	mediator
of	IN	of
liver	NN	liver
repair	NN	repair
and	CC	and
angiogenesis	NN	angiogenesis
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
pathological	JJ	pathological
angiogenesis	NN	angiogenesis
can	MD	can
be	VB	be
inefficient	JJ	inefficient
due	JJ	due
to	IN	to
the	DT	the
immaturity	NN	immaturity
and	CC	and
permeability	NN	permeability
of	IN	of
vascular	JJ	vascular
endothelial	NN	endothelial
growth	NN	growth
factor	NN	factor
(	-LRB-	(
VEGF)-induced	VBN	veg-o-induce
new	JJ	new
vessels	NNS	vessel
and	CC	and
,	,	,
consequently	RB	consequently
,	,	,
the	DT	the
liver	NN	liver
may	MD	may
be	VB	be
unable	JJ	unable
to	TO	to
reduce	VB	reduce
hypoxia	NN	hypoxia
.	.	.
</s>
<s type="decl">
Hypoxia	NN	hypoxia
up-regulates	VBZ	up-regulate
in	IN	in
vitro	NN	vitro
the	DT	the
expression	NN	expression
of	IN	of
APJ	NNP	APJ
in	IN	in
LX-2	NNP	LX-2
(	-LRB-	(
HSC	NNP	HSC
)	-RRB-	)
and	CC	and
in	IN	in
HepG2	NNP	HepG2
(	-LRB-	(
hepatocytes	NNS	hepatocyte
)	-RRB-	)
.	.	.
</s>
<s type="decl">
Interestingly	RB	interestingly
,	,	,
the	DT	the
pro-inflammatory	JJ	pro-inflammatory
and	CC	and
pro-fibrogenic	JJ	pro-fibrogenic
agents	NNS	agent
TNF-α	NNP	TNF-α
and	CC	and
AII	NNP	AII
also	RB	also
induce	VBP	induce
the	DT	the
expression	NN	expression
of	IN	of
APJ	NNP	APJ
in	IN	in
HepG2	NNP	HepG2
cells	NNS	cell
.	.	.
</s>
<s type="decl">
APJ	NNP	APJ
activation	NN	activation
in	IN	in
HepG2	NNP	HepG2
cells	NNS	cell
triggers	VBZ	trigger
the	DT	the
expression	NN	expression
of	IN	of
VEGF-A	NN	vegf-a
and	CC	and
PDGF-β	NN	PDGF-β
,	,	,
factors	NNS	factor
that	WDT	that
in	IN	in
turn	NN	turn
may	MD	may
promote	VB	promote
angiogenesis	NN	angiogenesis
and	CC	and
activation	NN	activation
of	IN	of
HSC	NNP	HSC
and	CC	and
,	,	,
consequently	RB	consequently
,	,	,
liver	NN	liver
fibrosis	NN	fibrosis
.	.	.
</s>
<s type="decl">
According	VBG	accord
to	IN	to
these	DT	this
data	NNS	datum
,	,	,
hypoxia	NN	hypoxia
,	,	,
inflammation	NN	inflammation
and	CC	and
pro-fibrogenic	JJ	pro-fibrogenic
factors	NNS	factor
up-regulate	VBP	up-regulate
APJ	NNP	APJ
in	IN	in
HSC	NN	HSC
and	CC	and
hepatocytes	NNS	hepatocyte
,	,	,
which	WDT	which
can	MD	can
release	VB	release
different	JJ	different
pro-angiogenic	JJ	pro-angiogenic
and	CC	and
pro-fibrogenic	JJ	pro-fibrogenic
factors	NNS	factor
such	JJ	such
as	IN	as
apelin	NN	apelin
(	-LRB-	(
from	IN	from
activated	VBN	activate
HSC	NNP	HSC
)	-RRB-	)
together	RB	together
to	TO	to
perpetuate	VB	perpetuate
fibrosis	NN	fibrosis
while	IN	while
injury	NN	injury
and	CC	and
these	DT	this
stimuli	NNS	stimulus
remain	VBP	remain
.	.	.
</s>
<s type="decl">
In	IN	in
vivo	NN	vivo
,	,	,
APJ	NNP	APJ
is	VBZ	be
upregulated	VBN	upregulate
preferentially	RB	preferentially
in	IN	in
hepatocytes	NNS	hepatocyte
and	CC	and
HSC	NNP	HSC
,	,	,
while	IN	while
apelin	NN	apelin
levels	NNS	level
are	VBP	be
increased	VBN	increase
and	CC	and
localized	VBN	localize
in	IN	in
HSC	NNP	HSC
in	IN	in
cirrhotic	JJ	cirrhotic
rats	NNS	rat
and	CC	and
in	IN	in
patients	NNS	patient
with	IN	with
liver	NN	liver
cirrhosis	NN	cirrhosis
caused	VBN	cause
by	IN	by
hepatitis	NNP	hepatitis
C	NNP	C
virus	NN	virus
or	CC	or
ethanol	NN	ethanol
.	.	.
</s>
<s type="decl">
High	JJ	high
apelin	NN	apelin
levels	NNS	level
and	CC	and
liver	NN	liver
damage	NN	damage
have	VBP	have
also	RB	also
been	VBN	be
observed	VBN	observe
in	IN	in
human	JJ	human
non-alcoholic	JJ	non-alcoholic
fatty	NN	fatty
liver	NN	liver
disease	NN	disease
.	.	.
</s>
<s type="decl">
A	DT	a
contemporary	JJ	contemporary
clinical	JJ	clinical
investigation	NN	investigation
revealed	VBD	reveal
that	IN	that
circulating	VBG	circulate
apelin	NN	apelin
levels	NNS	level
are	VBP	be
associated	VBN	associate
with	IN	with
histological	JJ	histological
and	CC	and
hemodynamic	JJ	hemodynamic
features	NNS	feature
of	IN	of
chronic	JJ	chronic
liver	NN	liver
disease	NN	disease
,	,	,
but	CC	but
more	JJR	more
clinical	JJ	clinical
studies	NNS	study
are	VBP	be
needed	VBN	need
to	TO	to
confirm	VB	confirm
the	DT	the
major	JJ	major
relevance	NN	relevance
of	IN	of
apelin	NN	apelin
system	NN	system
in	IN	in
human	JJ	human
liver	NN	liver
fibrosis	NN	fibrosis
.	.	.
</s>
</p>
</text>